NCT03201718

Brief Summary

Post-marketing surveillance study to evaluate the real world safety and effectiveness of Viekira/ Exviera (paritaprevir/ritonavir/ombitasvir and dasabuvir) administered under a normal, routine treatment practice by Korean patients with Hepatitis C.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
505

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

59 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 28, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

August 17, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2019

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

2.2 years

First QC Date

June 27, 2017

Last Update Submit

October 6, 2020

Conditions

Keywords

Hepatitis CParitaprevirRitonavirOmbitasvirDasabuvir

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants Achieving Sustained Virological Response 12 Weeks Post-treatment (SVR12)

    the lower limit of quantitation (LLOQ) SVR12 was defined as plasma hepatitis C virus ribonucleic acid (HCV RNA) level less than the lower limit of quantification \[\<LLOQ\]) 12 weeks after the last dose of study drug.

    12 weeks after the last dose of study drug

Secondary Outcomes (2)

  • Percentage of Participants With On-treatment Virologic Failure

    Up to 24 weeks

  • Percentage of Participants With Post-treatment Relapse

    From the end of treatment through 12 weeks after the last dose of study drug

Study Arms (1)

Hepatitis C

Participants with Hepatitis C receiving Viekira/Exviera (paritaprevir/ritonavir/ombitasvir and dasabuvir) for 12 or 24 weeks.

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Type C Hepatitis patients who had been prescribed Viekira/Exviera (paritaprevir/ritonavir/ombitasvir and dasabuvir) in accordance with approved local label.

You may qualify if:

  • Participants with type C hepatitis
  • Participants prescribed Viekira/Exviera in accordance with approved local label

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (59)

Dong-A University Hospital /ID# 167362

Busan, Busan Gwang Yeogsi, 49201, South Korea

Location

Pusan National University Hosp /ID# 167363

Busan, Busan Gwang Yeogsi, 602-739, South Korea

Location

Kyungpook National Univ Hosp /ID# 168731

Daegu, Daegu Gwang Yeogsi, 41944, South Korea

Location

Yeungnam University Med Ctr /ID# 167425

Daegu, Daegu Gwang Yeogsi, 42415, South Korea

Location

Chungnam National University Hospital /ID# 167724

Junggu, Daejeon Gwang Yeogsi, 35015, South Korea

Location

National health insurance cooperation ilsan hospital /ID# 201806

Goyang, Gyeonggido, 10444, South Korea

Location

Soon Chun Hyang University Hospital Bucheon /ID# 201803

Habun, Gyeonggido, 14584, South Korea

Location

Seoul National Univ Bundang ho /ID# 167394

Seongnam, Gyeonggido, 13620, South Korea

Location

St. Vincent's Hospital /ID# 201660

Suwon, Gyeonggido, 16247, South Korea

Location

Ajou University Hospital /ID# 167729

Suwon, Gyeonggido, 16499, South Korea

Location

Inje University Busan Paik Hospital /ID# 167392

Pusan, Gyeongsangbuk-do, 47392, South Korea

Location

Changwon Fatima Hospital /ID# 201664

Changwon, Gyeongsangnam-do, 51394, South Korea

Location

Inha University Hospital /ID# 201802

Junggu, Incheon Gwang Yeogsi, 22332, South Korea

Location

Chonnam National University Hospital /ID# 167423

Gwangju, Jeonranamdo, 61469, South Korea

Location

Kwangju Christian Hospital /ID# 210823

Gwangju, Jeonranamdo, 61661, South Korea

Location

Kyungpook National University Chilgok Hospital /ID# 201804

Daegu, Seoul Teugbyeolsi, 41404, South Korea

Location

SMG-SNU Boramae Medical Center /ID# 201805

Dongjak-gu, Seoul Teugbyeolsi, 07061, South Korea

Location

Kangbuk Samsung Hospital /ID# 168792

Jongno-Gu, Seoul Teugbyeolsi, 03181, South Korea

Location

Severance Hospital /ID# 167361

Seoul, Seoul Teugbyeolsi, 03722, South Korea

Location

Konkuk University Medical Ctr /ID# 167723

Seoul, Seoul Teugbyeolsi, 05030, South Korea

Location

Samsung Medical Center /ID# 167722

Seoul, Seoul Teugbyeolsi, 06351, South Korea

Location

Korea Universtiy Guro Hospital /ID# 167388

Seoul, Seoul Teugbyeolsi, 08308, South Korea

Location

Bucheon St. Mary's hospital /ID# 170782

Bucheon-si, 420-818, South Korea

Location

Dongnam Institute of Radiologi /ID# 167721

Busan, 46033, South Korea

Location

Good Samsun Hospital /ID# 167365

Busan, 47007, South Korea

Location

Haeundae Paik Hospital /ID# 170767

Busan, 48108, South Korea

Location

Maryknoll Medical Center /ID# 167418

Busan, 48972, South Korea

Location

Kosin University Gospel Hosp /ID# 168797

Busan, 602-702, South Korea

Location

Samsung Changwon Hospital /ID# 167732

Changwon, 630-723, South Korea

Location

Dankook University Hospital /ID# 167730

Cheonan, 330-715, South Korea

Location

Chuncheon Sacred Heart Hosp /ID# 167419

Chuncheon, 200-704, South Korea

Location

Kim Jun Hwan Sok Internal Medi /ID# 168794

Daegu, 42488, South Korea

Location

Keimyung Univ Dongsan medical /ID# 168793

Daegu, 700-712, South Korea

Location

Daegu Catholic University Med /ID# 167714

Daegu, 705-718, South Korea

Location

Daegu Catholic University Med /ID# 168729

Daegu, 705-718, South Korea

Location

The Catholic Univ. of Korea /ID# 167733

Daejeon, 301-723, South Korea

Location

Dongguk University Ilsan Hosp /ID# 168795

Goyang, 410-773, South Korea

Location

Myongji Hospital /ID# 170784

Goyang, 412-270, South Korea

Location

CHA Gumi Medical Center /ID# 170783

Gumi, 39295, South Korea

Location

Korea University Ansan Hosp /ID# 201661

Gyeonggi-do, 152-703, South Korea

Location

Dongtan Sacred Heart Hospital /ID# 170759

Hwaseong, 18450, South Korea

Location

The Catholic University of Korea Incheon St.Mary's Hospital /ID# 170769

Incheon, 21431, South Korea

Location

Presbyterian Medical Center /ID# 167424

Jeonju, 54987, South Korea

Location

CHA Bundang Medical Center /ID# 170757

Seongnam, 463-712, South Korea

Location

Bundang Jesaeng hospital /ID# 167725

Seongnam, 463-824, South Korea

Location

Korea University Anam Hospital /ID# 167731

Seoul, 02841, South Korea

Location

Seoul National University Hospital /ID# 167364

Seoul, 03080, South Korea

Location

Seoul National University Hospital /ID# 167389

Seoul, 03080, South Korea

Location

SoonChunHyang University Seoul /ID# 167711

Seoul, 04401, South Korea

Location

Asan Medical Center /ID# 167390

Seoul, 05505, South Korea

Location

Chung-Ang University Hostipal /ID# 167420

Seoul, 06973, South Korea

Location

Inje University Seoul Paik Hos /ID# 167426

Seoul, 100-032, South Korea

Location

Inje University Sanggye Paik H /ID# 167427

Seoul, 139-707, South Korea

Location

St. Carollo General Hospital /ID# 167712

Suncheon, 57931, South Korea

Location

Uijeongbu St. Mary's Hospital /ID# 168730

Uijeongbu-si, 480-717, South Korea

Location

Ulsan University Hospital /ID# 168796

Ulsan, 682-714, South Korea

Location

Wonju Severance Christian Hosp /ID# 167713

Wŏnju, 220-701, South Korea

Location

Pusan National University Yang /ID# 167710

Yangsan, 50612, South Korea

Location

Yeosoo Hankook Hospital /ID# 168728

Yeosu, 59684, South Korea

Location

Related Links

MeSH Terms

Conditions

Hepatitis C

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System Diseases

Study Officials

  • AbbVie Inc.

    AbbVie

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2017

First Posted

June 28, 2017

Study Start

August 17, 2017

Primary Completion

October 11, 2019

Study Completion

October 11, 2019

Last Updated

October 8, 2020

Record last verified: 2020-10

Locations